Cost Matrix of Molecular Pathology in Glioma—Towards AI-Driven Rational Molecular Testing and Precision Care for the Future

Gliomas are the most common and aggressive primary brain tumors. Gliomas carry a poor prognosis because of the tumor’s resistance to radiation and chemotherapy leading to nearly universal recurrence. Recent advances in large-scale genomic research have allowed for the development of more targeted th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagasia, Sarisha, Tasci, Erdal, Zhuge, Ying, Camphausen, Kevin, Krauze, Andra Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775648/
https://www.ncbi.nlm.nih.gov/pubmed/36551786
http://dx.doi.org/10.3390/biomedicines10123029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775648/
https://www.ncbi.nlm.nih.gov/pubmed/36551786
http://dx.doi.org/10.3390/biomedicines10123029

Ejemplares similares